High-dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69-year-old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high-dose oral LT4 as a therapeutic option in myxedema coma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628197 | PMC |
| http://dx.doi.org/10.1002/ccr3.1131 | DOI Listing |
Publication Analysis
Top Keywords
myxedema coma
16
split high-dose
8
high-dose oral
8
oral levothyroxine
8
option myxedema
8
levothyroxine treatment
4
treatment successful
4
successful therapy
4
therapy option
4
myxedema
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!